Biozentrum, University of Basel

Aparições nos rankings

Os melhores dias em que posts desta conta entraram na lista diária do Debya.

Esta conta ainda não apareceu em um ranking diário.

Posts curtidos recentemente

Curtidas públicas da rede Bluesky.

• BIOspektrum@claudialudy.bsky.social11/09/2026 13:29

  Ein Team von @helmholtzmunich.bsky.social, der @tum.de und dem @biozentrum.unibas.ch hat mit MemBrain v2 ein KI-Werkzeug entwickelt, das Zellmembranen automatisiert ausliest. www.nature.com/articles/s41... @lorenzlamm.bsky.social @tingyingpeng.bsky.social

  Ver post
• Yuping Li@yuping-li.bsky.social04/09/2026 07:32

  We are thrilled and grateful that our project is funded by #ERCStG via @erc.europa.eu . This will allow us to uncover how the widespread jumbophage killer sensor recognizes the invasion of phiKZ-like jumbophages, which form fascinating vesicle & nucleus compartments during infection.

  Ver post
• University of Basel@unibas.ch03/09/2026 11:59

  Six female scientists at the University of Basel have been awarded one of the prestigious ERC Starting Grants. Prof. Petya Apostolova @dixonlab.bsky.social @yuping-li.bsky.social Dr. Cathelijne Nuijsink Prof. Olena Palko Prof. Burcu Tepekule

  Ver post
• European Research Council (ERC)@erc.europa.eu03/09/2026 11:53

  📣 Good news! 📣 Results of the ERC 2026 Starting Grant call are out! Funding worth a total of €705 million will go to 421 early-career researchers across Europe. Discover who, what and where 👉 link.europa.eu/9M3MmN 🧪 #ERCStG #FrontierResearch #HorizonEurope 🇪🇺 @scienceinnovation.ec.europa.eu

  Ver post
• Informationsdienst Wissenschaft - idw@idw-online.de03/09/2026 11:52

  CAR-T-Zellen direkt im Körper herstellen ERC Starting Grant für Karl Petri: Würzburger Forscher entwickelt neue Technologie für eine sichere und dauerhafte In-vivo-CAR-T-Zelltherapie... weiterlesen

  Ver post

Entre para ver mais

Contas que bloqueia

No Bluesky, bloqueios são registros públicos.

Esta conta não bloqueia ninguém.